secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-09-15T22:15:34+00:00
Accession:  0001493152-26-042791
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma issues 3.74M common shares on preferred conversions; adds warrants for ~17.9M shares
--------------------------------------------------------------------------------

- As of Sept 14, 2026, issued 2,869,595 common shares on Series B-1 preferred conversion and 867,887 on Series B-2 conversion.
- Issued warrants to purchase ~927,114 shares at $10.30 per share, exercisable for 3 years.
- Issued pre-funded warrants to purchase ~16,932,508 shares of common stock.
- All securities sold unregistered under Section 4(a)(2) exemption, following stockholder approval at Sept 9 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/0001493152-26-042791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer